Correspondence 0001628280-23-018278 from Paratek Pharmaceuticals, Inc. (CIK 0001178711)
Paratek Pharmaceuticals, Inc. (CIK 0001178711)
Date: May 15, 2023 · CIK: 0001178711 · Accession: 0001628280-23-018278
AI Filing Summary & Sentiment
File numbers found in text: 333-271780
Letter
Document
PARATEK PHARMACEUTICALS, INC.
75 Park Plaza
Boston, MA 02116
May 15, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Stacey Gama
Re: Paratek Pharmaceuticals, Inc.
Registration Statement on Form S-3 (File No. 333-271780)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Paratek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on May 17, 2023, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective.
[Signature page follows]
135713953_2
Very truly yours,
PARATEK PHARMACEUTICALS, INC.
Show Raw Text
CORRESP
1
filename1.htm
Document
PARATEK PHARMACEUTICALS, INC.
75 Park Plaza
Boston, MA 02116
May 15, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Stacey Gama
Re: Paratek Pharmaceuticals, Inc.
Registration Statement on Form S-3 (File No. 333-271780)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Paratek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on May 17, 2023, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Thomas Danielski of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 as soon as the registration statement has been declared effective.
[Signature page follows]
135713953_2
Very truly yours,
PARATEK PHARMACEUTICALS, INC.
By: /s/ Evan Loh, M.D.
Name: Evan Loh, M.D.
Title: Chief Executive Officer
[Signature Page to Acceleration Request]
135713953_2